<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01225211</url>
  </required_header>
  <id_info>
    <org_study_id>VX09-809-102</org_study_id>
    <secondary_id>2010-020413-90</secondary_id>
    <nct_id>NCT01225211</nct_id>
  </id_info>
  <brief_title>Study of VX-809 Alone and in Combination With VX-770 in Cystic Fibrosis (CF) Patients Homozygous or Heterozygous for the F508del-CFTR Mutation</brief_title>
  <official_title>A Phase 2, Multicenter, Double-Blinded, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Lumacaftor Monotherapy, and Lumacaftor and Ivacaftor Combination Therapy in Subjects With Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vertex Pharmaceuticals Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vertex Pharmaceuticals Incorporated</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate of the safety, efficacy, pharmacokinetics (PK) and
      pharmacodynamic (PD) effects of lumacaftor (VX-809) alone and when coadministered with
      ivacaftor (VX-770) in participants with cystic fibrosis, homozygous or heterozygous for the
      F508del-CFTR mutation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cohort 1: Safety and Tolerability Based on Adverse Events (AEs)</measure>
    <time_frame>Cohort 1: Day 1 up to 28 days after last dose (Last dose = Day 21)</time_frame>
    <description>AE: any untoward medical occurrence in a participant during study; irrespective of relationship with treatment. This includes any newly occurring event or previous condition that has increased in severity or frequency after informed consent. AE includes serious AEs (SAEs) as well as Non-SAEs. SAE (subset of AE): medical event or condition, which falls into any of the following categories, regardless of its relationship to study drug: death, life threatening adverse experience, in-patient hospitalization/prolongation of hospitalization, persistent/significant disability or incapacity, congenital anomaly/birth defect, important medical event. Number of participants with AEs and SAEs are reported. AE that started at/after initial dosing of study drug, or increased in severity after initial dosing of study drug is considered treatment-emergent. Results are reported separately for monotherapy period (Period 1: Day 1 to Day 14) and combination therapy period (Period 2: Day 15 to Day 21).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cohort 2 and 3: Safety and Tolerability Based on Adverse Events (AEs)</measure>
    <time_frame>Cohort 2 and 3: Day 1 up to 28 days after last dose (Last dose = Day 56)</time_frame>
    <description>Detailed description is provided in Outcome Measure 1. Results are reported separately for monotherapy period (Period 1: Day 1 to Day 28) and combination therapy period (Period 2: Day 29 to Day 56).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cohort 4: Safety and Tolerability Assessed by Number of Participants With AEs and SAEs</measure>
    <time_frame>Cohort 4: Day 1 up to 28 days after last dose (Last dose = Day 56)</time_frame>
    <description>AEs and SAEs are defined in Outcome Measure 1.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cohort 1: Absolute Change From Day 14 in Sweat Chloride at Day 21</measure>
    <time_frame>Cohort 1: Day 14, Day 21</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cohort 2 And 3: Absolute Change From Day 28 in Sweat Chloride at Day 56</measure>
    <time_frame>Cohort 2 and 3: Day 28, Day 56</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cohort 4: Absolute Change From Baseline in Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1) at Day 56</measure>
    <time_frame>Cohort 4: Baseline, Day 56</time_frame>
    <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. ppFEV1 (predicted for age, gender, and height) was calculated using the Hankinson method.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cohort 1: Absolute Change From Baseline in Sweat Chloride at Day 14</measure>
    <time_frame>Cohort 1: Baseline, Day 14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cohort 2 And 3: Absolute Change From Baseline in Sweat Chloride at Day 14</measure>
    <time_frame>Cohort 2: Baseline, Day 14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cohort 4: Absolute Change From Baseline in Sweat Chloride at Day 56</measure>
    <time_frame>Cohort 4: Baseline, Day 56</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cohort 1: Absolute Change From Day 14 in FEV1 at Day 21</measure>
    <time_frame>Cohort 1: Day 14, Day 21</time_frame>
    <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cohort 1: Absolute Change From Day 14 in ppFEV1 at Day 21</measure>
    <time_frame>Cohort 1: Day 14, Day 21</time_frame>
    <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cohort 2 and 3: Absolute Change From Day 28 in ppFEV1 at Day 56</measure>
    <time_frame>Cohort 2 and 3: Day 28, Day 56</time_frame>
    <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cohort 2 and 3: Relative Change From Day 28 in ppFEV1 at Day 56</measure>
    <time_frame>Cohort 2 and 3: Day 28, Day 56</time_frame>
    <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cohort 2 and 3: Absolute Change From Baseline in ppFEV1 at Day 28 and 56</measure>
    <time_frame>Cohort 2 and 3: Baseline, Day 28 and 56</time_frame>
    <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cohort 2 and 3: Relative Change From Baseline in FEV1 at Day 28 and 56</measure>
    <time_frame>Cohort 2 and 3: Baseline, Day 28 and 56</time_frame>
    <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cohort 4: Relative Change From Baseline in Percent Predicted FEV1 at Day 56</measure>
    <time_frame>Cohort 4: Baseline, Day 56</time_frame>
    <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cohort 2 and 3: Absolute Change From Day 28 in Cystic Fibrosis Questionnaire-Revised (CFQ-R) Respiratory Domain Score at Day 56</measure>
    <time_frame>Cohort 2 and 3: Day 28, Day 56</time_frame>
    <description>The CFQ-R is a validated participant-reported outcome measuring health-related quality of life for subjects with cystic fibrosis. Respiratory domain assessed respiratory symptoms (for example, coughing, congestion, wheezing), score range: 0-100; higher scores indicating fewer symptoms and better health-related quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cohort 4: Absolute Change From Baseline in CFQ-R Respiratory Domain Score at Day 56</measure>
    <time_frame>Cohort 4: Baseline, Day 56</time_frame>
    <description>CFQ-R respiratory domain is defined in Outcome Measure 17.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cohort 4: Absolute Change From Baseline in Body Mass Index (BMI) at Day 56</measure>
    <time_frame>Cohort 4: Baseline, Day 56</time_frame>
    <description>BMI was defined as weight in kilogram (kg) divided by height*height in square meter (m^2).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cohort 4: Absolute Change From Baseline in Weight at Day 56</measure>
    <time_frame>Cohort 4: Baseline, Day 56</time_frame>
  </secondary_outcome>
  <number_of_arms>10</number_of_arms>
  <enrollment type="Actual">312</enrollment>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>Cohort 1: Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants homozygous (HO) for the F508del-CF transmembrane conductance regulator gene (CFTR) mutation received lumacaftor matched placebo once daily (qd) (Day 1 through Day 14), followed by lumacaftor matched placebo qd in combination with ivacaftor matched placebo every 12 hours (q12h) (Day 15 through Day 21).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 1: LUM 200 mg qd/LUM 200 mg qd+IVA 150 mg q12h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants homozygous for the F508del-CFTR mutation received 200 milligram (mg) of lumacaftor (LUM) qd (Day 1 through Day 14), followed by 200 mg of lumacaftor qd in combination with 150 mg of ivacaftor (IVA) q12h (Day 15 through Day 21).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 1: LUM 200 mg qd/LUM 200 mg qd+IVA 250 mg q12h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor alone qd (Day 1 through Day 14), followed by 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 15 through Day 21).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 2 and 3: Placebo (HO and HE)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd (Day 1 through Day 28), followed by lumacaftor matched placebo in combination with ivacaftor matched placebo q12h (Day 29 through Day 56).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 2: LUM 200 mg qd/LUM 200 mg qd+IVA 250 mg q12h (HO)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 2: LUM 400 mg qd/LUM 400 mg qd+IVA 250 mg q12h (HO)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 400 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 2: LUM 600 mg qd/LUM 600 mg qd+IVA 250 mg q12h (HO&amp;HE)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received 600 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 3: LUM 400 mg q12h/LUM 400 mg q12h+IVA 250 mg q12h (HO)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor alone q12h (Day 1 through Day 28), followed by 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 4: Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants heterozygous for the F508del-CFTR mutation received lumacaftor matched placebo in combination with ivacaftor matched placebo q12h (Day 1 through Day 56).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 4: LUM 400 mg q12h+IVA 250 mg q12h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants heterozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 1 through Day 56).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lumacaftor</intervention_name>
    <description>Tablet</description>
    <arm_group_label>Cohort 1: LUM 200 mg qd/LUM 200 mg qd+IVA 150 mg q12h</arm_group_label>
    <arm_group_label>Cohort 1: LUM 200 mg qd/LUM 200 mg qd+IVA 250 mg q12h</arm_group_label>
    <arm_group_label>Cohort 2: LUM 200 mg qd/LUM 200 mg qd+IVA 250 mg q12h (HO)</arm_group_label>
    <arm_group_label>Cohort 2: LUM 400 mg qd/LUM 400 mg qd+IVA 250 mg q12h (HO)</arm_group_label>
    <arm_group_label>Cohort 2: LUM 600 mg qd/LUM 600 mg qd+IVA 250 mg q12h (HO&amp;HE)</arm_group_label>
    <arm_group_label>Cohort 3: LUM 400 mg q12h/LUM 400 mg q12h+IVA 250 mg q12h (HO)</arm_group_label>
    <arm_group_label>Cohort 4: LUM 400 mg q12h+IVA 250 mg q12h</arm_group_label>
    <other_name>VX-809, LUM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ivacaftor</intervention_name>
    <description>Tablet.</description>
    <arm_group_label>Cohort 1: LUM 200 mg qd/LUM 200 mg qd+IVA 150 mg q12h</arm_group_label>
    <arm_group_label>Cohort 1: LUM 200 mg qd/LUM 200 mg qd+IVA 250 mg q12h</arm_group_label>
    <arm_group_label>Cohort 2: LUM 200 mg qd/LUM 200 mg qd+IVA 250 mg q12h (HO)</arm_group_label>
    <arm_group_label>Cohort 2: LUM 400 mg qd/LUM 400 mg qd+IVA 250 mg q12h (HO)</arm_group_label>
    <arm_group_label>Cohort 2: LUM 600 mg qd/LUM 600 mg qd+IVA 250 mg q12h (HO&amp;HE)</arm_group_label>
    <arm_group_label>Cohort 3: LUM 400 mg q12h/LUM 400 mg q12h+IVA 250 mg q12h (HO)</arm_group_label>
    <arm_group_label>Cohort 4: LUM 400 mg q12h+IVA 250 mg q12h</arm_group_label>
    <other_name>VX-770, IVA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lumacaftor Placebo</intervention_name>
    <description>Matching placebo tablet.</description>
    <arm_group_label>Cohort 1: Placebo</arm_group_label>
    <arm_group_label>Cohort 2 and 3: Placebo (HO and HE)</arm_group_label>
    <arm_group_label>Cohort 4: Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ivacaftor Placebo</intervention_name>
    <description>Matching placebo tablet.</description>
    <arm_group_label>Cohort 1: Placebo</arm_group_label>
    <arm_group_label>Cohort 2 and 3: Placebo (HO and HE)</arm_group_label>
    <arm_group_label>Cohort 4: Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female participants with confirmed diagnosis of CF

          -  Must have the F508del-CFTR mutation on at least 1 allele.

          -  FEV1 greater than equal (&gt;=) 40% of predicted normal for age, gender, and height
             (Knudson standards)(Cohort 1, 2, and 3); FEV1 40-90% of predicted normal for age,
             gender, and height (Hankinson standards (Cohort 4)

          -  Participant of child-bearing potential and who are sexually active must meet the
             contraception requirements

        Exclusion Criteria:

          -  History of any illness or condition that, in the opinion of the investigator might
             confound the results of the study or pose an additional risk in administering study
             drug to the participant (e.g., cirrhosis with portal hypertension).

          -  An acute illness including acute upper or lower respiratory infection, pulmonary
             exacerbation or changes in therapy (including antibiotics) for pulmonary disease
             within 14 days (Cohort 1, 2, and 3) or 28 days (Cohort 4) before receiving the first
             dose of study drug.

          -  History of solid organ or hematological transplantation.

          -  History of alcohol abuse or drug addiction in the past year, including cannabis,
             cocaine, and opiates.

          -  Ongoing participation in another therapeutic clinical study, or prior participation in
             an investigational drug study without appropriate washout

          -  Pregnant or nursing females; females of childbearing potential who are unwilling or
             unable to use an acceptable method of non-hormonal contraception

          -  Participants enrolled in Cohort 1 or Cohort 2 will not be eligible for Cohort 3

          -  Ongoing or prior participation in an investigational drug study within 30 days of the
             Screening Visit

          -  Heterozygous participants who participated in Cohort 2 and meet the eligibility
             criteria for Cohort 4 may participate in Cohort 4

          -  Evidence of lens opacity or cataract as determined by the ophthalmologic examination
             (Cohort 4 only)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pittsburg</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Adelaide</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brisbane</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chermside</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nedlands</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Parkville Victoria</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Westmead</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pierre Benite Cedex</city>
        <state>Rhone</state>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jena</city>
        <state>Thueringen</state>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bochum</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Koeln</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Christchurch</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>New Zealand</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Ireland</country>
  </removed_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2010</study_first_submitted>
  <study_first_submitted_qc>October 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2010</study_first_posted>
  <results_first_submitted>August 1, 2015</results_first_submitted>
  <results_first_submitted_qc>September 2, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 5, 2015</results_first_posted>
  <disposition_first_submitted>May 8, 2015</disposition_first_submitted>
  <disposition_first_submitted_qc>May 8, 2015</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">June 2, 2015</disposition_first_posted>
  <last_update_submitted>September 2, 2015</last_update_submitted>
  <last_update_submitted_qc>September 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ivacaftor</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants in each cohort are mutually exclusive. A total of 312 participants were randomized of which one participant did not receive any treatment and a total of 311 participants were treated.</recruitment_details>
      <pre_assignment_details>Study included 4 cohorts which were studied in sequential manner. For results reporting, combined placebo arm was reported for Cohort 2 and 3 and results for these 2 cohorts are reported collectively.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Cohort 1: Placebo</title>
          <description>Participants homozygous (HO) for the F508del-CF transmembrane conductance regulator gene (CFTR) mutation received lumacaftor matched placebo once daily (qd) (Day 1 through Day 14), followed by lumacaftor matched placebo qd in combination with ivacaftor matched placebo every 12 hours (q12h) (Day 15 through Day 21).</description>
        </group>
        <group group_id="P2">
          <title>Cohort 1: LUM 200 mg qd/LUM 200 mg qd+IVA 150 mg q12h</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 200 milligram (mg) of lumacaftor (LUM) qd (Day 1 through Day 14), followed by 200 mg of lumacaftor qd in combination with 150 mg of ivacaftor (IVA) q12h (Day 15 through Day 21).</description>
        </group>
        <group group_id="P3">
          <title>Cohort 1: LUM 200 mg qd/LUM 200 mg qd+IVA 250 mg q12h</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor alone qd (Day 1 through Day 14), followed by 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 15 through Day 21).</description>
        </group>
        <group group_id="P4">
          <title>Cohort 2 and 3: Placebo (HO and HE)</title>
          <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd (Day 1 through Day 28), followed by lumacaftor matched placebo in combination with ivacaftor matched placebo q12h (Day 29 through Day 56).</description>
        </group>
        <group group_id="P5">
          <title>Cohort 2: LUM 200 mg qd/LUM 200 mg qd+IVA 250 mg q12h (HO)</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
        </group>
        <group group_id="P6">
          <title>Cohort 2: LUM 400 mg qd/LUM 400 mg qd+IVA 250 mg q12h (HO)</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 400 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
        </group>
        <group group_id="P7">
          <title>Cohort 2: LUM 600 mg qd/LUM 600 mg qd+IVA 250 mg q12h (HO&amp;HE)</title>
          <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received 600 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
        </group>
        <group group_id="P8">
          <title>Cohort 3: LUM 400 mg q12h/LUM 400 mg q12h+IVA 250 mg q12h (HO)</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor alone q12h (Day 1 through Day 28), followed by 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
        </group>
        <group group_id="P9">
          <title>Cohort 4: Placebo</title>
          <description>Participants heterozygous for the F508del-CFTR mutation received lumacaftor in combination with ivacaftor matched placebo q12h (Day 1 through Day 56).</description>
        </group>
        <group group_id="P10">
          <title>Cohort 4: LUM 400 mg q12h+IVA 250 mg q12h</title>
          <description>Participants heterozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 1 through Day 56).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="21"/>
                <participants group_id="P4" count="27"/>
                <participants group_id="P5" count="23"/>
                <participants group_id="P6" count="21"/>
                <participants group_id="P7" count="42"/>
                <participants group_id="P8" count="11"/>
                <participants group_id="P9" count="63"/>
                <participants group_id="P10" count="62"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
                <participants group_id="P4" count="27"/>
                <participants group_id="P5" count="23"/>
                <participants group_id="P6" count="21"/>
                <participants group_id="P7" count="41"/>
                <participants group_id="P8" count="11"/>
                <participants group_id="P9" count="62"/>
                <participants group_id="P10" count="57"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Full Analysis Set (FAS) for Cohort 1, 2, and 3 included all randomized participants who received at least 1 dose of study drug and FAS for Cohort 4 included all randomized participants who received any amount of study drug.</population>
      <group_list>
        <group group_id="B1">
          <title>Cohort 1: Placebo</title>
          <description>Participants homozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd (Day 1 through Day 14), followed by lumacaftor matched placebo qd in combination with ivacaftor matched placebo q12h (Day 15 through Day 21).</description>
        </group>
        <group group_id="B2">
          <title>Cohort 1: LUM 200 mg qd/LUM 200 mg qd+IVA 150 mg q12h</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor alone qd (Day 1 through Day 14), followed by 200 mg of lumacaftor qd in combination with 150 mg of ivacaftor q12h (Day 15 through Day 21).</description>
        </group>
        <group group_id="B3">
          <title>Cohort 1: LUM 200 mg qd/LUM 200 mg qd+IVA 250 mg q12h</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor alone qd (Day 1 through Day 14), followed by 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 15 through Day 21).</description>
        </group>
        <group group_id="B4">
          <title>Cohort 2 and 3: Placebo (HO and HE)</title>
          <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd (Day 1 through Day 28), followed by lumacaftor matched placebo in combination with ivacaftor matched placebo q12h (Day 29 through Day 56).</description>
        </group>
        <group group_id="B5">
          <title>Cohort 2: LUM 200 mg qd/LUM 200 mg qd+IVA 250 mg q12h (HO)</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
        </group>
        <group group_id="B6">
          <title>Cohort 2: LUM 400 mg qd/LUM 400 mg qd+IVA 250 mg q12h (HO)</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 400 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
        </group>
        <group group_id="B7">
          <title>Cohort 2: LUM 600 mg qd/LUM 600 mg qd+IVA 250 mg q12h (HO&amp;HE)</title>
          <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received 600 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
        </group>
        <group group_id="B8">
          <title>Cohort 3: LUM 400 mg q12h/LUM 400 mg q12h+IVA 250 mg q12h (HO)</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor alone q12h (Day 1 through Day 28), followed by 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
        </group>
        <group group_id="B9">
          <title>Cohort 4: Placebo</title>
          <description>Participants heterozygous for the F508del-CFTR mutation received lumacaftor in combination with ivacaftor matched placebo q12h (Day 1 through Day 56).</description>
        </group>
        <group group_id="B10">
          <title>Cohort 4: LUM 400 mg q12h+IVA 250 mg q12h</title>
          <description>Participants heterozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 1 through Day 56).</description>
        </group>
        <group group_id="B11">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="21"/>
            <count group_id="B4" value="27"/>
            <count group_id="B5" value="23"/>
            <count group_id="B6" value="21"/>
            <count group_id="B7" value="42"/>
            <count group_id="B8" value="11"/>
            <count group_id="B9" value="63"/>
            <count group_id="B10" value="62"/>
            <count group_id="B11" value="311"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="27"/>
                    <measurement group_id="B5" value="23"/>
                    <measurement group_id="B6" value="21"/>
                    <measurement group_id="B7" value="42"/>
                    <measurement group_id="B8" value="11"/>
                    <measurement group_id="B9" value="63"/>
                    <measurement group_id="B10" value="62"/>
                    <measurement group_id="B11" value="311"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="11"/>
                    <measurement group_id="B6" value="9"/>
                    <measurement group_id="B7" value="19"/>
                    <measurement group_id="B8" value="5"/>
                    <measurement group_id="B9" value="31"/>
                    <measurement group_id="B10" value="29"/>
                    <measurement group_id="B11" value="144"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="18"/>
                    <measurement group_id="B5" value="12"/>
                    <measurement group_id="B6" value="12"/>
                    <measurement group_id="B7" value="23"/>
                    <measurement group_id="B8" value="6"/>
                    <measurement group_id="B9" value="32"/>
                    <measurement group_id="B10" value="33"/>
                    <measurement group_id="B11" value="167"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cohort 1: Safety and Tolerability Based on Adverse Events (AEs)</title>
        <description>AE: any untoward medical occurrence in a participant during study; irrespective of relationship with treatment. This includes any newly occurring event or previous condition that has increased in severity or frequency after informed consent. AE includes serious AEs (SAEs) as well as Non-SAEs. SAE (subset of AE): medical event or condition, which falls into any of the following categories, regardless of its relationship to study drug: death, life threatening adverse experience, in-patient hospitalization/prolongation of hospitalization, persistent/significant disability or incapacity, congenital anomaly/birth defect, important medical event. Number of participants with AEs and SAEs are reported. AE that started at/after initial dosing of study drug, or increased in severity after initial dosing of study drug is considered treatment-emergent. Results are reported separately for monotherapy period (Period 1: Day 1 to Day 14) and combination therapy period (Period 2: Day 15 to Day 21).</description>
        <time_frame>Cohort 1: Day 1 up to 28 days after last dose (Last dose = Day 21)</time_frame>
        <population>Cohort 1 Safety Set included all participants who received at least 1 dose of study drug in Cohort 1. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1: Placebo  Period 1</title>
            <description>Participants homozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd (Day 1 through Day 14).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1: LUM 200 mg qd  Period 1</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor alone qd (Day 1 through Day 14).</description>
          </group>
          <group group_id="O3">
            <title>Cohort 1: Placebo  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd in combination with ivacaftor matched placebo q12h (Day 15 through Day 21).</description>
          </group>
          <group group_id="O4">
            <title>Cohort 1: LUM 200 mg qd+IVA 150 mg q12h  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor qd in combination with 150 mg of ivacaftor q12h (Day 15 through Day 21).</description>
          </group>
          <group group_id="O5">
            <title>Cohort 1: LUM 200 mg qd+IVA 250 mg q12h  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 15 through Day 21).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 1: Safety and Tolerability Based on Adverse Events (AEs)</title>
          <description>AE: any untoward medical occurrence in a participant during study; irrespective of relationship with treatment. This includes any newly occurring event or previous condition that has increased in severity or frequency after informed consent. AE includes serious AEs (SAEs) as well as Non-SAEs. SAE (subset of AE): medical event or condition, which falls into any of the following categories, regardless of its relationship to study drug: death, life threatening adverse experience, in-patient hospitalization/prolongation of hospitalization, persistent/significant disability or incapacity, congenital anomaly/birth defect, important medical event. Number of participants with AEs and SAEs are reported. AE that started at/after initial dosing of study drug, or increased in severity after initial dosing of study drug is considered treatment-emergent. Results are reported separately for monotherapy period (Period 1: Day 1 to Day 14) and combination therapy period (Period 2: Day 15 to Day 21).</description>
          <population>Cohort 1 Safety Set included all participants who received at least 1 dose of study drug in Cohort 1. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="20"/>
                <count group_id="O5" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Participants with any AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="29"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Participants with SAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cohort 2 and 3: Safety and Tolerability Based on Adverse Events (AEs)</title>
        <description>Detailed description is provided in Outcome Measure 1. Results are reported separately for monotherapy period (Period 1: Day 1 to Day 28) and combination therapy period (Period 2: Day 29 to Day 56).</description>
        <time_frame>Cohort 2 and 3: Day 1 up to 28 days after last dose (Last dose = Day 56)</time_frame>
        <population>Cohort 2 and 3 Safety Set included all participants who received at least 1 dose of study drug in Cohort 2 or 3. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 2 and 3: Placebo (HO and HE)  Period 1</title>
            <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd (Day 1 through Day 28).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 2: LUM 200 mg qd  Period 1</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor alone qd (Day 1 through Day 28).</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2: LUM 400 mg qd  Period 1</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor alone qd (Day 1 through Day 28).</description>
          </group>
          <group group_id="O4">
            <title>Cohort 2: LUM 600 mg qd  Period 1</title>
            <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received 600 mg of lumacaftor alone qd (Day 1 through Day 28).</description>
          </group>
          <group group_id="O5">
            <title>Cohort 3: LUM 400 mg q12h  Period 1</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor alone q12h (Day 1 through Day 28).</description>
          </group>
          <group group_id="O6">
            <title>Cohort 2 and 3: Placebo (HO and HE)  Period 2</title>
            <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received lumacaftor matched placebo in combination with ivacaftor matched placebo q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O7">
            <title>Cohort 2: LUM 200 mg qd+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O8">
            <title>Cohort 2: LUM 400 mg qd+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O9">
            <title>Cohort 2: LUM 600 mg qd+IVA 250 mg q12h (HO&amp;HE)  Period 2</title>
            <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O10">
            <title>Cohort 3: LUM 400 mg q12h+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 2 and 3: Safety and Tolerability Based on Adverse Events (AEs)</title>
          <description>Detailed description is provided in Outcome Measure 1. Results are reported separately for monotherapy period (Period 1: Day 1 to Day 28) and combination therapy period (Period 2: Day 29 to Day 56).</description>
          <population>Cohort 2 and 3 Safety Set included all participants who received at least 1 dose of study drug in Cohort 2 or 3. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="11"/>
                <count group_id="O6" value="27"/>
                <count group_id="O7" value="21"/>
                <count group_id="O8" value="20"/>
                <count group_id="O9" value="38"/>
                <count group_id="O10" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Participants with any AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="37"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="20"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="15"/>
                    <measurement group_id="O9" value="26"/>
                    <measurement group_id="O10" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Participants with SAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="4"/>
                    <measurement group_id="O10" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cohort 4: Safety and Tolerability Assessed by Number of Participants With AEs and SAEs</title>
        <description>AEs and SAEs are defined in Outcome Measure 1.</description>
        <time_frame>Cohort 4: Day 1 up to 28 days after last dose (Last dose = Day 56)</time_frame>
        <population>Cohort 4 Safety Set included all participants who received at least 1 dose of study drug in Cohort 4.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 4: Placebo</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received lumacaftor in combination with ivacaftor matched placebo q12h (Day 1 through Day 56).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 4: Active Study Drug</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 1 through Day 56).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 4: Safety and Tolerability Assessed by Number of Participants With AEs and SAEs</title>
          <description>AEs and SAEs are defined in Outcome Measure 1.</description>
          <population>Cohort 4 Safety Set included all participants who received at least 1 dose of study drug in Cohort 4.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Participants with any AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O2" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Participants with SAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cohort 1: Absolute Change From Day 14 in Sweat Chloride at Day 21</title>
        <time_frame>Cohort 1: Day 14, Day 21</time_frame>
        <population>Cohort 1 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 1. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1: LUM 200 mg qd+IVA 150 mg q12h  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor qd in combination with 150 mg of ivacaftor q12h (Day 15 through Day 21).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1: LUM 200 mg qd+IVA 250 mg q12h  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 15 through Day 21).</description>
          </group>
          <group group_id="O3">
            <title>Cohort 1: Placebo  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd in combination with ivacaftor matched placebo q12h (Day 15 through Day 21).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 1: Absolute Change From Day 14 in Sweat Chloride at Day 21</title>
          <population>Cohort 1 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 1. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>millimole per liter (mmol/L)</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.131" lower_limit="-5.381" upper_limit="1.119"/>
                    <measurement group_id="O2" value="-9.128" lower_limit="-12.893" upper_limit="-5.362"/>
                    <measurement group_id="O3" value="0.548" lower_limit="-2.955" upper_limit="4.052"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.267</p_value>
            <method>ANCOVA</method>
            <param_type>LS Mean difference</param_type>
            <param_value>-2.679</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-7.484</ci_lower_limit>
            <ci_upper_limit>2.125</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>ANCOVA</method>
            <param_type>LS Mean difference</param_type>
            <param_value>-9.676</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-14.801</ci_lower_limit>
            <ci_upper_limit>-4.551</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cohort 2 And 3: Absolute Change From Day 28 in Sweat Chloride at Day 56</title>
        <time_frame>Cohort 2 and 3: Day 28, Day 56</time_frame>
        <population>Cohort 2 and 3 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 2 or 3. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 2: LUM 200 mg qd+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 2: LUM 400 mg qd+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2: LUM 600 mg qd+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O4">
            <title>Cohort 2: LUM 600 mg qd+IVA 250 mg q12h (HE)  Period 2</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O5">
            <title>Cohort 3: LUM 400 mg q12h+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O6">
            <title>Cohort 2 and 3: Placebo (HO and HE)  Period 2</title>
            <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received lumacaftor matched placebo in combination with ivacaftor matched placebo q12h (Day 29 through Day 56).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 2 And 3: Absolute Change From Day 28 in Sweat Chloride at Day 56</title>
          <population>Cohort 2 and 3 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 2 or 3. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>mmol/L</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="17"/>
                <count group_id="O5" value="9"/>
                <count group_id="O6" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.321" lower_limit="-4.208" upper_limit="4.849"/>
                    <measurement group_id="O2" value="-1.043" lower_limit="-5.800" upper_limit="3.714"/>
                    <measurement group_id="O3" value="-2.900" lower_limit="-7.542" upper_limit="1.743"/>
                    <measurement group_id="O4" value="-1.240" lower_limit="-6.287" upper_limit="3.807"/>
                    <measurement group_id="O5" value="-2.154" lower_limit="-9.177" upper_limit="4.870"/>
                    <measurement group_id="O6" value="1.627" lower_limit="-2.661" upper_limit="5.915"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.680</p_value>
            <method>ANCOVA</method>
            <param_type>LS Mean difference</param_type>
            <param_value>-1.306</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-7.565</ci_lower_limit>
            <ci_upper_limit>4.953</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.409</p_value>
            <method>ANCOVA</method>
            <param_type>LS Mean difference</param_type>
            <param_value>-2.670</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-9.053</ci_lower_limit>
            <ci_upper_limit>3.712</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.161</p_value>
            <method>ANCOVA</method>
            <param_type>LS Mean difference</param_type>
            <param_value>-4.526</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-10.888</ci_lower_limit>
            <ci_upper_limit>1.835</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.396</p_value>
            <method>ANCOVA</method>
            <param_type>LS Mean difference</param_type>
            <param_value>-2.867</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-9.543</ci_lower_limit>
            <ci_upper_limit>3.810</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.365</p_value>
            <method>ANCOVA</method>
            <param_type>LS Mean difference</param_type>
            <param_value>-3.780</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-12.028</ci_lower_limit>
            <ci_upper_limit>4.467</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cohort 4: Absolute Change From Baseline in Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1) at Day 56</title>
        <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. ppFEV1 (predicted for age, gender, and height) was calculated using the Hankinson method.</description>
        <time_frame>Cohort 4: Baseline, Day 56</time_frame>
        <population>Cohort 4 Full Analysis Set included all randomized participants who received any amount of study drug in Cohort 4. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 4: Placebo</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received lumacaftor in combination with ivacaftor matched placebo q12h (Day 1 through Day 56).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 4: LUM 400 mg q12h+IVA 250 mg q12h</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 1 through Day 56).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 4: Absolute Change From Baseline in Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1) at Day 56</title>
          <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. ppFEV1 (predicted for age, gender, and height) was calculated using the Hankinson method.</description>
          <population>Cohort 4 Full Analysis Set included all randomized participants who received any amount of study drug in Cohort 4. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>percent predicted of FEV1</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.23" spread="0.801"/>
                    <measurement group_id="O2" value="-0.62" spread="0.829"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.5978</p_value>
            <method>Mixed Model Repeated Measure (MMRM)</method>
            <param_type>LS Mean difference</param_type>
            <param_value>0.60</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.66</ci_lower_limit>
            <ci_upper_limit>2.86</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cohort 1: Absolute Change From Baseline in Sweat Chloride at Day 14</title>
        <time_frame>Cohort 1: Baseline, Day 14</time_frame>
        <population>Cohort 1 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 1. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1: LUM 200 mg qd  Period 1</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor alone qd (Day 1 through Day 14).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1: Placebo  Period 1</title>
            <description>Participants homozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd (Day 1 through Day 14).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 1: Absolute Change From Baseline in Sweat Chloride at Day 14</title>
          <population>Cohort 1 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 1. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>mmol/L</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.442" lower_limit="-7.141" upper_limit="-1.742"/>
                    <measurement group_id="O2" value="-1.668" lower_limit="-5.606" upper_limit="2.271"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cohort 2 And 3: Absolute Change From Baseline in Sweat Chloride at Day 14</title>
        <time_frame>Cohort 2: Baseline, Day 14</time_frame>
        <population>Cohort 2 and 3 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 2 or 3. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 2: LUM 200 mg qd  Period 1</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor alone qd (Day 1 through Day 28).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 2: LUM 400 mg qd  Period 1</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor alone qd (Day 1 through Day 28).</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2: LUM 600 mg qd (HO)  Period 1</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 600 mg of lumacaftor alone qd (Day 1 through Day 28).</description>
          </group>
          <group group_id="O4">
            <title>Cohort 2: LUM 600 mg qd (HE)  Period 1</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received 600 mg of lumacaftor alone qd (Day 1 through Day 28).</description>
          </group>
          <group group_id="O5">
            <title>Cohort 3: LUM 400 mg q12h  Period 1</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor alone q12h (Day 1 through Day 28).</description>
          </group>
          <group group_id="O6">
            <title>Cohort 2 and 3: Placebo (HO and HE)  Period 1</title>
            <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd (Day 1 through Day 28).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 2 And 3: Absolute Change From Baseline in Sweat Chloride at Day 14</title>
          <population>Cohort 2 and 3 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 2 or 3. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>mmol/L</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="17"/>
                <count group_id="O5" value="11"/>
                <count group_id="O6" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.490" lower_limit="-11.226" upper_limit="-1.755"/>
                    <measurement group_id="O2" value="-5.901" lower_limit="-10.910" upper_limit="-0.892"/>
                    <measurement group_id="O3" value="-9.442" lower_limit="-13.953" upper_limit="-4.931"/>
                    <measurement group_id="O4" value="-3.137" lower_limit="-8.167" upper_limit="1.893"/>
                    <measurement group_id="O5" value="-9.179" lower_limit="-15.470" upper_limit="-2.888"/>
                    <measurement group_id="O6" value="0.048" lower_limit="-4.162" upper_limit="4.258"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cohort 4: Absolute Change From Baseline in Sweat Chloride at Day 56</title>
        <time_frame>Cohort 4: Baseline, Day 56</time_frame>
        <population>Cohort 4 Full Analysis Set included all randomized participants who received any amount of study drug in Cohort 4. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 4: Placebo</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received lumacaftor in combination with ivacaftor matched placebo q12h (Day 1 through Day 56).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 4: LUM 400 mg q12h+IVA 250 mg q12h</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 1 through Day 56).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 4: Absolute Change From Baseline in Sweat Chloride at Day 56</title>
          <population>Cohort 4 Full Analysis Set included all randomized participants who received any amount of study drug in Cohort 4. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>mmol/L</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.78" spread="1.230"/>
                    <measurement group_id="O2" value="-11.82" spread="1.281"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cohort 1: Absolute Change From Day 14 in FEV1 at Day 21</title>
        <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration.</description>
        <time_frame>Cohort 1: Day 14, Day 21</time_frame>
        <population>Cohort 1 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 1. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1: LUM 200 mg qd+IVA 150 mg q12h  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor qd in combination with 150 mg of ivacaftor q12h (Day 15 through Day 21).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1: LUM 200 mg qd+IVA 250 mg q12h  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 15 through Day 21).</description>
          </group>
          <group group_id="O3">
            <title>Cohort 1: Placebo  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd in combination with ivacaftor matched placebo q12h (Day 15 through Day 21).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 1: Absolute Change From Day 14 in FEV1 at Day 21</title>
          <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration.</description>
          <population>Cohort 1 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 1. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>liters</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.128" lower_limit="0.030" upper_limit="0.225"/>
                    <measurement group_id="O2" value="0.015" lower_limit="-0.094" upper_limit="0.124"/>
                    <measurement group_id="O3" value="-0.046" lower_limit="-0.138" upper_limit="0.047"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cohort 1: Absolute Change From Day 14 in ppFEV1 at Day 21</title>
        <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
        <time_frame>Cohort 1: Day 14, Day 21</time_frame>
        <population>Cohort 1 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 1. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 1: LUM 200 mg qd+IVA 150 mg q12h  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor qd in combination with 150 mg of ivacaftor q12h (Day 15 through Day 21).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 1: LUM 200 mg qd+IVA 250 mg q12h  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 15 through Day 21).</description>
          </group>
          <group group_id="O3">
            <title>Cohort 1: Placebo  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd in combination with ivacaftor matched placebo q12h (Day 15 through Day 21).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 1: Absolute Change From Day 14 in ppFEV1 at Day 21</title>
          <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
          <population>Cohort 1 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 1. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>percent predicted of FEV1</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.46" lower_limit="0.87" upper_limit="6.05"/>
                    <measurement group_id="O2" value="0.63" lower_limit="-2.20" upper_limit="3.46"/>
                    <measurement group_id="O3" value="-1.44" lower_limit="-3.89" upper_limit="1.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cohort 2 and 3: Absolute Change From Day 28 in ppFEV1 at Day 56</title>
        <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
        <time_frame>Cohort 2 and 3: Day 28, Day 56</time_frame>
        <population>Cohort 2 and 3 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 2 or 3. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 2: LUM 200 mg qd+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 2: LUM 400 mg qd+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2: LUM 600 mg qd+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O4">
            <title>Cohort 2: LUM 600 mg qd+IVA 250 mg q12h (HE)  Period 2</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O5">
            <title>Cohort 3: LUM 400 mg q12h+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O6">
            <title>Cohort 2 and 3: Placebo (HO and HE)  Period 2</title>
            <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received lumacaftor matched placebo in combination with ivacaftor matched placebo q12h (Day 29 through Day 56).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 2 and 3: Absolute Change From Day 28 in ppFEV1 at Day 56</title>
          <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
          <population>Cohort 2 and 3 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 2 or 3. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>percent predicted of FEV1</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="17"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.96" lower_limit="-0.84" upper_limit="4.76"/>
                    <measurement group_id="O2" value="1.99" lower_limit="-0.87" upper_limit="4.84"/>
                    <measurement group_id="O3" value="6.15" lower_limit="3.27" upper_limit="9.02"/>
                    <measurement group_id="O4" value="2.29" lower_limit="-0.82" upper_limit="5.39"/>
                    <measurement group_id="O5" value="6.09" lower_limit="2.02" upper_limit="10.16"/>
                    <measurement group_id="O6" value="-1.57" lower_limit="-4.24" upper_limit="1.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cohort 2 and 3: Relative Change From Day 28 in ppFEV1 at Day 56</title>
        <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
        <time_frame>Cohort 2 and 3: Day 28, Day 56</time_frame>
        <population>Cohort 2 and 3 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 2 or 3. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 2: LUM 200 mg qd+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 2: LUM 400 mg qd+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2: LUM 600 mg qd+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O4">
            <title>Cohort 2: LUM 600 mg qd+IVA 250 mg q12h (HE)  Period 2</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O5">
            <title>Cohort 3: LUM 400 mg q12h+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O6">
            <title>Cohort 2 and 3: Placebo (HO and HE)  Period 2</title>
            <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received lumacaftor matched placebo in combination with ivacaftor matched placebo q12h (Day 29 through Day 56).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 2 and 3: Relative Change From Day 28 in ppFEV1 at Day 56</title>
          <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
          <population>Cohort 2 and 3 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 2 or 3. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>percent change</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="17"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.13" lower_limit="-1.29" upper_limit="7.54"/>
                    <measurement group_id="O2" value="2.98" lower_limit="-1.52" upper_limit="7.48"/>
                    <measurement group_id="O3" value="9.70" lower_limit="5.17" upper_limit="14.23"/>
                    <measurement group_id="O4" value="4.30" lower_limit="-0.59" upper_limit="9.19"/>
                    <measurement group_id="O5" value="8.24" lower_limit="1.83" upper_limit="14.65"/>
                    <measurement group_id="O6" value="-2.05" lower_limit="-6.25" upper_limit="2.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cohort 2 and 3: Absolute Change From Baseline in ppFEV1 at Day 28 and 56</title>
        <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
        <time_frame>Cohort 2 and 3: Baseline, Day 28 and 56</time_frame>
        <population>Cohort 2 and 3 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 2 or 3. Here, n = participants evaluable for specified category for each arm, respectively. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 2: LUM 200 mg qd/LUM 200 mg qd+IVA 250 mg q12h (HO)</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 2: LUM 400 mg qd/LUM 400 mg qd+IVA 250 mg q12h (HO)</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 400 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2: LUM 600 mg qd/LUM 600 mg qd+IVA 250 mg q12h (HO)</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 600 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O4">
            <title>Cohort 2: LUM 600 mg qd/LUM 600 mg qd+IVA 250 mg q12h (HE)</title>
            <description>Participants heterozygous (HE) for the F508del-CFTR mutation received 600 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O5">
            <title>Cohort 3: LUM 400 mg q12h/LUM 400 mg q12h+IVA 250 mg q12h (HO)</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor alone q12h (Day 1 through Day 28), followed by 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O6">
            <title>Cohort 2 and 3: Placebo (HO and HE)</title>
            <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd (Day 1 through Day 28), followed by lumacaftor matched placebo in combination with ivacaftor matched placebo q12h (Day 29 through Day 56).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 2 and 3: Absolute Change From Baseline in ppFEV1 at Day 28 and 56</title>
          <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
          <population>Cohort 2 and 3 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 2 or 3. Here, n = participants evaluable for specified category for each arm, respectively. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>percent predicted of FEV1</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="21"/>
                <count group_id="O5" value="11"/>
                <count group_id="O6" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 28: (n= 21, 20, 20, 18, 11, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.21" lower_limit="-2.77" upper_limit="3.19"/>
                    <measurement group_id="O2" value="-1.35" lower_limit="-4.39" upper_limit="1.69"/>
                    <measurement group_id="O3" value="-2.62" lower_limit="-5.67" upper_limit="0.42"/>
                    <measurement group_id="O4" value="-3.82" lower_limit="-7.03" upper_limit="-0.61"/>
                    <measurement group_id="O5" value="-4.52" lower_limit="-8.65" upper_limit="-0.39"/>
                    <measurement group_id="O6" value="-0.03" lower_limit="-2.68" upper_limit="2.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 56: (n= 21, 20, 20, 17, 10, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.82" lower_limit="-1.28" upper_limit="4.91"/>
                    <measurement group_id="O2" value="0.64" lower_limit="-2.52" upper_limit="3.80"/>
                    <measurement group_id="O3" value="3.59" lower_limit="0.41" upper_limit="6.77"/>
                    <measurement group_id="O4" value="-1.68" lower_limit="-5.12" upper_limit="1.75"/>
                    <measurement group_id="O5" value="2.16" lower_limit="-2.34" upper_limit="6.66"/>
                    <measurement group_id="O6" value="-2.02" lower_limit="-4.97" upper_limit="0.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cohort 2 and 3: Relative Change From Baseline in FEV1 at Day 28 and 56</title>
        <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
        <time_frame>Cohort 2 and 3: Baseline, Day 28 and 56</time_frame>
        <population>Cohort 2 and 3 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 2 or 3. Here, n = participants evaluable for specified category for each arm, respectively. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 2: LUM 200 mg qd/LUM 200 mg qd+IVA 250 mg q12h (HO)</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 2: LUM 400 mg qd/LUM 400 mg qd+IVA 250 mg q12h (HO)</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 400 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2: LUM 600 mg qd/LUM 600 mg qd+IVA 250 mg q12h (HO)</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 600 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O4">
            <title>Cohort 2: LUM 600 mg qd/LUM 600 mg qd+IVA 250 mg q12h (HE)</title>
            <description>Participants heterozygous (HE) for the F508del-CFTR mutation received 600 mg of lumacaftor alone qd (Day 1 through Day 28), followed by 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O5">
            <title>Cohort 3: LUM 400 mg q12h/LUM 400 mg q12h+IVA 250 mg q12h (HO)</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor alone q12h (Day 1 through Day 28), followed by 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O6">
            <title>Cohort 2 and 3: Placebo (HO and HE)</title>
            <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd (Day 1 through Day 28), followed by lumacaftor matched placebo in combination with ivacaftor matched placebo q12h (Day 29 through Day 56).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 2 and 3: Relative Change From Baseline in FEV1 at Day 28 and 56</title>
          <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
          <population>Cohort 2 and 3 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 2 or 3. Here, n = participants evaluable for specified category for each arm, respectively. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>percent change</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="21"/>
                <count group_id="O4" value="21"/>
                <count group_id="O5" value="11"/>
                <count group_id="O6" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 28: (n= 21, 20, 20, 18, 11, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" lower_limit="-4.27" upper_limit="4.75"/>
                    <measurement group_id="O2" value="-1.15" lower_limit="-5.75" upper_limit="3.45"/>
                    <measurement group_id="O3" value="-3.13" lower_limit="-7.74" upper_limit="1.48"/>
                    <measurement group_id="O4" value="-5.46" lower_limit="-10.32" upper_limit="-0.60"/>
                    <measurement group_id="O5" value="-6.39" lower_limit="-12.65" upper_limit="-0.14"/>
                    <measurement group_id="O6" value="1.89" lower_limit="-2.12" upper_limit="5.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 56: (n= 21, 20, 20, 17, 10, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.51" lower_limit="-2.21" upper_limit="7.23"/>
                    <measurement group_id="O2" value="1.72" lower_limit="-3.09" upper_limit="6.53"/>
                    <measurement group_id="O3" value="5.55" lower_limit="0.70" upper_limit="10.39"/>
                    <measurement group_id="O4" value="-2.34" lower_limit="-7.57" upper_limit="2.89"/>
                    <measurement group_id="O5" value="2.96" lower_limit="-3.90" upper_limit="9.81"/>
                    <measurement group_id="O6" value="-2.42" lower_limit="-6.91" upper_limit="2.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cohort 4: Relative Change From Baseline in Percent Predicted FEV1 at Day 56</title>
        <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
        <time_frame>Cohort 4: Baseline, Day 56</time_frame>
        <population>Cohort 4 Full Analysis Set included all randomized participants who received any amount of study drug in Cohort 4. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 4: Placebo</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received lumacaftor in combination with ivacaftor matched placebo q12h (Day 1 through Day 56).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 4: LUM 400 mg q12h+IVA 250 mg q12h</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 1 through Day 56).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 4: Relative Change From Baseline in Percent Predicted FEV1 at Day 56</title>
          <description>FEV1 and ppFEV1 are defined in Outcome Measure 6.</description>
          <population>Cohort 4 Full Analysis Set included all randomized participants who received any amount of study drug in Cohort 4. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>percent change</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.20" spread="1.373"/>
                    <measurement group_id="O2" value="-0.69" spread="1.423"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cohort 2 and 3: Absolute Change From Day 28 in Cystic Fibrosis Questionnaire-Revised (CFQ-R) Respiratory Domain Score at Day 56</title>
        <description>The CFQ-R is a validated participant-reported outcome measuring health-related quality of life for subjects with cystic fibrosis. Respiratory domain assessed respiratory symptoms (for example, coughing, congestion, wheezing), score range: 0-100; higher scores indicating fewer symptoms and better health-related quality of life.</description>
        <time_frame>Cohort 2 and 3: Day 28, Day 56</time_frame>
        <population>Cohort 2 and 3 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 2 or 3. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 2: LUM 200 mg qd+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 2: LUM 400 mg qd+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O3">
            <title>Cohort 2: LUM 600 mg qd+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O4">
            <title>Cohort 2: LUM 600 mg qd+IVA 250 mg q12h (HE)  Period 2</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O5">
            <title>Cohort 3: LUM 400 mg q12h+IVA 250 mg q12h (HO)  Period 2</title>
            <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
          </group>
          <group group_id="O6">
            <title>Cohort 2 and 3: Placebo (HO and HE)  Period 2</title>
            <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received lumacaftor matched placebo in combination with ivacaftor matched placebo q12h (Day 29 through Day 56).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 2 and 3: Absolute Change From Day 28 in Cystic Fibrosis Questionnaire-Revised (CFQ-R) Respiratory Domain Score at Day 56</title>
          <description>The CFQ-R is a validated participant-reported outcome measuring health-related quality of life for subjects with cystic fibrosis. Respiratory domain assessed respiratory symptoms (for example, coughing, congestion, wheezing), score range: 0-100; higher scores indicating fewer symptoms and better health-related quality of life.</description>
          <population>Cohort 2 and 3 Full Analysis Set included all randomized participants who received at least 1 dose of study drug in Cohort 2 or 3. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="17"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" lower_limit="-3.6" upper_limit="10.1"/>
                    <measurement group_id="O2" value="7.9" lower_limit="0.8" upper_limit="14.9"/>
                    <measurement group_id="O3" value="8.9" lower_limit="1.9" upper_limit="15.9"/>
                    <measurement group_id="O4" value="5.5" lower_limit="-2.1" upper_limit="13.1"/>
                    <measurement group_id="O5" value="11.2" lower_limit="1.3" upper_limit="21.1"/>
                    <measurement group_id="O6" value="-8.6" lower_limit="-14.9" upper_limit="-2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cohort 4: Absolute Change From Baseline in CFQ-R Respiratory Domain Score at Day 56</title>
        <description>CFQ-R respiratory domain is defined in Outcome Measure 17.</description>
        <time_frame>Cohort 4: Baseline, Day 56</time_frame>
        <population>Cohort 4 Full Analysis Set included all randomized participants who received any amount of study drug in Cohort 4. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 4: Placebo</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received lumacaftor in combination with ivacaftor matched placebo q12h (Day 1 through Day 56).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 4: LUM 400 mg q12h+IVA 250 mg q12h</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 1 through Day 56).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 4: Absolute Change From Baseline in CFQ-R Respiratory Domain Score at Day 56</title>
          <description>CFQ-R respiratory domain is defined in Outcome Measure 17.</description>
          <population>Cohort 4 Full Analysis Set included all randomized participants who received any amount of study drug in Cohort 4. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.82" spread="1.802"/>
                    <measurement group_id="O2" value="5.66" spread="1.864"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cohort 4: Absolute Change From Baseline in Body Mass Index (BMI) at Day 56</title>
        <description>BMI was defined as weight in kilogram (kg) divided by height*height in square meter (m^2).</description>
        <time_frame>Cohort 4: Baseline, Day 56</time_frame>
        <population>Cohort 4 Full Analysis Set included all randomized participants who received any amount of study drug in Cohort 4. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 4: Placebo</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received lumacaftor in combination with ivacaftor matched placebo q12h (Day 1 through Day 56).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 4: LUM 400 mg q12h+IVA 250 mg q12h</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 1 through Day 56).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 4: Absolute Change From Baseline in Body Mass Index (BMI) at Day 56</title>
          <description>BMI was defined as weight in kilogram (kg) divided by height*height in square meter (m^2).</description>
          <population>Cohort 4 Full Analysis Set included all randomized participants who received any amount of study drug in Cohort 4. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>kg/m^2</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.075"/>
                    <measurement group_id="O2" value="-0.04" spread="0.077"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cohort 4: Absolute Change From Baseline in Weight at Day 56</title>
        <time_frame>Cohort 4: Baseline, Day 56</time_frame>
        <population>Cohort 4 Full Analysis Set included all randomized participants who received any amount of study drug in Cohort 4. Number of participants analysed signifies participants evaluable for this outcome.</population>
        <group_list>
          <group group_id="O1">
            <title>Cohort 4: Placebo</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received lumacaftor in combination with ivacaftor matched placebo q12h (Day 1 through Day 56).</description>
          </group>
          <group group_id="O2">
            <title>Cohort 4: LUM 400 mg q12h+IVA 250 mg q12h</title>
            <description>Participants heterozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 1 through Day 56).</description>
          </group>
        </group_list>
        <measure>
          <title>Cohort 4: Absolute Change From Baseline in Weight at Day 56</title>
          <population>Cohort 4 Full Analysis Set included all randomized participants who received any amount of study drug in Cohort 4. Number of participants analysed signifies participants evaluable for this outcome.</population>
          <units>kg</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.211"/>
                    <measurement group_id="O2" value="-0.11" spread="0.216"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Cohort 1: Day 1 up to 28 days after last dose (Last dose = Day 21); Cohort 2 and 3: Day 1 up to 28 days after last dose (Last dose = Day 56); Cohort 4: Day 1 up to 28 days after last dose (Last dose = Day 56)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Cohort 1: LUM 200 mg qd  Period 1</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor alone qd (Day 1 through Day 14).</description>
        </group>
        <group group_id="E2">
          <title>Cohort 1: LUM 200 mg qd+IVA 150 mg q12h  Period 2</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor qd in combination with 150 mg of ivacaftor q12h (Day 15 through Day 21).</description>
        </group>
        <group group_id="E3">
          <title>Cohort 1: LUM 200 mg qd+IVA 250 mg q12h  Period 2</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 15 through Day 21).</description>
        </group>
        <group group_id="E4">
          <title>Cohort 1: Placebo  Period 1</title>
          <description>Participants homozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd (Day 1 through Day 14).</description>
        </group>
        <group group_id="E5">
          <title>Cohort 1: Placebo  Period 2</title>
          <description>Participants homozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd in combination with ivacaftor matched placebo q12h (Day 15 through Day 21).</description>
        </group>
        <group group_id="E6">
          <title>Cohort 2: LUM 200 mg qd  Period 1</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor alone qd (Day 1 through Day 28).</description>
        </group>
        <group group_id="E7">
          <title>Cohort 2: LUM 400 mg qd  Period 1</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor alone qd (Day 1 through Day 28).</description>
        </group>
        <group group_id="E8">
          <title>Cohort 2: LUM 600 mg qd  Period 1</title>
          <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received 600 mg of lumacaftor alone qd (Day 1 through Day 28).</description>
        </group>
        <group group_id="E9">
          <title>Cohort 3: LUM 400 mg q12h  Period 1</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor alone q12h (Day 1 through Day 28).</description>
        </group>
        <group group_id="E10">
          <title>Cohort 2 and 3: Placebo (HO and HE)  Period 1</title>
          <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received lumacaftor matched placebo qd (Day 1 through Day 28).</description>
        </group>
        <group group_id="E11">
          <title>Cohort 2: LUM 200 mg qd+IVA 250 mg q12h (HO)  Period 2</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 200 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
        </group>
        <group group_id="E12">
          <title>Cohort 2: LUM 400 mg qd+IVA 250 mg q12h (HO)  Period 2</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
        </group>
        <group group_id="E13">
          <title>Cohort 2: LUM 600 mg qd+IVA 250 mg q12h (HO&amp;HE)  Period 2</title>
          <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received 600 mg of lumacaftor qd in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
        </group>
        <group group_id="E14">
          <title>Cohort 3: LUM 400 mg q12h+IVA 250 mg q12h (HO)  Period 2</title>
          <description>Participants homozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 29 through Day 56).</description>
        </group>
        <group group_id="E15">
          <title>Cohort 2 and 3: Placebo (HO and HE)  Period 2</title>
          <description>Participants homozygous or heterozygous for the F508del-CFTR mutation received lumacaftor matched placebo in combination with ivacaftor matched placebo q12h (Day 29 through Day 56).</description>
        </group>
        <group group_id="E16">
          <title>Cohort 4: Placebo</title>
          <description>Participants heterozygous for the F508del-CFTR mutation received lumacaftor in combination with ivacaftor matched placebo q12h (Day 1 through Day 56).</description>
        </group>
        <group group_id="E17">
          <title>Cohort 4: LUM 400 mg q12h+IVA 250 mg q12h</title>
          <description>Participants heterozygous for the F508del-CFTR mutation received 400 mg of lumacaftor q12h in combination with 250 mg of ivacaftor q12h (Day 1 through Day 56).</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (12.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="42"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="38"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="4" subjects_at_risk="27"/>
                <counts group_id="E16" subjects_affected="5" subjects_at_risk="63"/>
                <counts group_id="E17" subjects_affected="9" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>CYSTIC FIBROSIS LUNG</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="3" subjects_affected="3" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="4" subjects_affected="4" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>HYPERSENSITIVITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infective pulmonary exacerbation of cystic fibrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="4" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E17" events="7" subjects_affected="7" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PNEUMONIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Spirometry abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>BLOOD CREATINE PHOSPHOKINASE INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>DYSPNOEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>RESPIRATION ABNORMAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA (12.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="41"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="20"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="21"/>
                <counts group_id="E5" subjects_affected="15" subjects_at_risk="21"/>
                <counts group_id="E6" subjects_affected="17" subjects_at_risk="23"/>
                <counts group_id="E7" subjects_affected="18" subjects_at_risk="21"/>
                <counts group_id="E8" subjects_affected="37" subjects_at_risk="42"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="23" subjects_at_risk="27"/>
                <counts group_id="E11" subjects_affected="12" subjects_at_risk="21"/>
                <counts group_id="E12" subjects_affected="15" subjects_at_risk="20"/>
                <counts group_id="E13" subjects_affected="26" subjects_at_risk="38"/>
                <counts group_id="E14" subjects_affected="10" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="20" subjects_at_risk="27"/>
                <counts group_id="E16" subjects_affected="53" subjects_at_risk="63"/>
                <counts group_id="E17" subjects_affected="51" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>LYMPHADENOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Eosinophilia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Increased tendency to bruise</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>SINUS BRADYCARDIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>CYSTIC FIBROSIS LUNG</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E8" events="7" subjects_affected="7" subjects_at_risk="42"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="3" subjects_affected="3" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="4" subjects_affected="4" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Cystic fibrosis related diabetes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>EAR PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>EAR DISCOMFORT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>EAR DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>TINNITUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="3" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>EYELID OEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>CONJUNCTIVITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Vision Blurred</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>DIARRHOEA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="21"/>
                <counts group_id="E8" events="5" subjects_affected="5" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="9" subjects_affected="5" subjects_at_risk="63"/>
                <counts group_id="E17" events="7" subjects_affected="7" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN UPPER</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E16" events="10" subjects_affected="7" subjects_at_risk="63"/>
                <counts group_id="E17" events="5" subjects_affected="5" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>ABDOMINAL DISCOMFORT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="3" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="5" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="3" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="8" subjects_affected="8" subjects_at_risk="42"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="3" subjects_affected="3" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="3" subjects_affected="3" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E16" events="9" subjects_affected="7" subjects_at_risk="63"/>
                <counts group_id="E17" events="7" subjects_affected="7" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="2" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E17" events="4" subjects_affected="4" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>ABDOMINAL DISTENSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN LOWER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>FLATULENCE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="21"/>
                <counts group_id="E8" events="3" subjects_affected="3" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>GASTROOESOPHAGEAL REFLUX DISEASE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="7" subjects_affected="5" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>HYPOAESTHESIA ORAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>CONSTIPATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>DISTAL ILEAL OBSTRUCTION SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>DRY MOUTH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>DYSPEPSIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="3" subjects_affected="3" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>RECTAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>TOOTHACHE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>FREQUENT BOWEL MOVEMENTS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="3" subjects_affected="2" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>FAECAL VOLUME INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>DYSPHAGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>LIP SWELLING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>POST-TUSSIVE VOMITING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>STEATORRHOEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>FATIGUE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="4" subjects_affected="3" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="6" subjects_affected="6" subjects_at_risk="63"/>
                <counts group_id="E17" events="6" subjects_affected="4" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PYREXIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="7" subjects_affected="6" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="4" subjects_affected="3" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="10" subjects_affected="9" subjects_at_risk="63"/>
                <counts group_id="E17" events="7" subjects_affected="7" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PAIN</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="3" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>APPLICATION SITE PRURITUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>CATHETER SITE HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>CATHETER SITE PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>CHEST DISCOMFORT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>CHILLS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="3" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>FEELING HOT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="4" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>INJECTION SITE HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Exercise tolerance decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Vessel puncture site bruise</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>NON-CARDIAC CHEST PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="2" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>APPLICATION SITE IRRITATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>FEELING OF BODY TEMPERATURE CHANGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="2" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>INFLUENZA LIKE ILLNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatomegaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>VIRAL INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>RHINITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>UPPER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="5" subjects_affected="5" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="3" subjects_affected="3" subjects_at_risk="21"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E13" events="3" subjects_affected="3" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="4" subjects_affected="4" subjects_at_risk="27"/>
                <counts group_id="E16" events="4" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E17" events="3" subjects_affected="3" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>BACTERIAL DISEASE CARRIER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>CANDIDIASIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>ORAL HERPES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>VIRAL UPPER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="4" subjects_affected="4" subjects_at_risk="63"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Infective pulmonary exacerbation of cystic fibrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="11" subjects_affected="10" subjects_at_risk="63"/>
                <counts group_id="E17" events="8" subjects_affected="7" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>NASOPHARYNGITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="6" subjects_affected="6" subjects_at_risk="63"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>ORAL CANDIDIASIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PHARYNGITIS STREPTOCOCCAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Rash pustular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Bronchopulmonary aspergillosis allergic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>INFLUENZA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Kidney infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Vulvovaginal mycotic infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>SINUSITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>FUNGAL INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>HERPES SIMPLEX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>LARYNGITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>OTITIS MEDIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PHARYNGITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>RHINOVIRUS INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>VIRAL RASH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>CHEST INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>EXCORIATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>JOINT SPRAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>LIMB INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>MUSCLE STRAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>THERMAL BURN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Arthropod sting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>JOINT INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>SUNBURN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>VERTEBRAL INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Animal bite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>ARTHROPOD BITE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>BLOOD GLUCOSE INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>C-REACTIVE PROTEIN INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="5" subjects_affected="5" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="6" subjects_affected="5" subjects_at_risk="63"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>GLUCOSE URINE PRESENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>LIVER FUNCTION TEST ABNORMAL</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PROTHROMBIN TIME PROLONGED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PULMONARY FUNCTION TEST DECREASED</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E17" events="3" subjects_affected="2" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>ALANINE AMINOTRANSFERASE INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="4" subjects_affected="4" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>BLOOD IMMUNOGLOBULIN E INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>BLOOD SODIUM DECREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>BLOOD URINE PRESENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>HEPATIC ENZYME INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>INTERNATIONAL NORMALISED RATIO INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Forced expiratory volume decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="4" subjects_affected="4" subjects_at_risk="63"/>
                <counts group_id="E17" events="4" subjects_affected="4" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="4" subjects_affected="4" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="3" subjects_affected="3" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Sputum abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Blood alkaline phosphatase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Blood creatinine decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Blood immunoglobulin G increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Blood lactate dehydrogenase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Chest X-ray abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Eosinophil count increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Gamma-glutamyltransferase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Interleukin level increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="3" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Protein total increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>WHITE BLOOD CELL COUNT INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>BLOOD GLUCOSE DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>NEUTROPHIL COUNT INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>BACTERIA URINE IDENTIFIED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>BLOOD PHOSPHORUS DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>BLOOD POTASSIUM INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>CULTURE THROAT POSITIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>ELECTROCARDIOGRAM QT PROLONGED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>FUNGUS SPUTUM TEST POSITIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PLATELET COUNT DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PROTEIN URINE PRESENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>URINE KETONE BODY PRESENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>WHITE BLOOD CELLS URINE POSITIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>HYPOGLYCAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>DEHYDRATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="4" subjects_affected="4" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>ANOREXIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>HYPERCALCAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>HYPERGLYCAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ARTHRALGIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="2" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL CHEST PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="6" subjects_affected="2" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PAIN IN EXTREMITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>MUSCLE SPASMS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>MYALGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="3" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Clubbing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Osteopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL DISCOMFORT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>COSTOCHONDRITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>MEDIAL TIBIAL STRESS SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>MUSCLE TIGHTNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL STIFFNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>NECK PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>TORTICOLLIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>DIZZINESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>SINUS HEADACHE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>MIGRAINE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="3" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>TREMOR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>TUNNEL VISION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="5" subjects_affected="4" subjects_at_risk="21"/>
                <counts group_id="E5" events="7" subjects_affected="5" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="4" subjects_affected="4" subjects_at_risk="21"/>
                <counts group_id="E8" events="7" subjects_affected="4" subjects_at_risk="42"/>
                <counts group_id="E9" events="2" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="9" subjects_affected="5" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E13" events="10" subjects_affected="7" subjects_at_risk="38"/>
                <counts group_id="E14" events="3" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" events="7" subjects_affected="5" subjects_at_risk="27"/>
                <counts group_id="E16" events="18" subjects_affected="11" subjects_at_risk="63"/>
                <counts group_id="E17" events="4" subjects_affected="3" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>NEURALGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PRESYNCOPE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>LETHARGY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>DYSGEUSIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>ANXIETY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>INSOMNIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>MOOD SWINGS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>DEPRESSED MOOD</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Abnormal dreams</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="2" subjects_affected="1" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>PYURIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Chromaturia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>DYSURIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PROTEINURIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>DYSMENORRHOEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>MENSTRUATION DELAYED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>BREAST TENDERNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>MENOMETRORRHAGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>MENORRHAGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>MENSTRUAL DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Vulvovaginal burning sensation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Vulvovaginal discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>COUGH</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="41"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="4" subjects_affected="4" subjects_at_risk="21"/>
                <counts group_id="E6" events="3" subjects_affected="3" subjects_at_risk="23"/>
                <counts group_id="E7" events="8" subjects_affected="8" subjects_at_risk="21"/>
                <counts group_id="E8" events="13" subjects_affected="12" subjects_at_risk="42"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="6" subjects_affected="6" subjects_at_risk="27"/>
                <counts group_id="E11" events="5" subjects_affected="3" subjects_at_risk="21"/>
                <counts group_id="E12" events="5" subjects_affected="5" subjects_at_risk="20"/>
                <counts group_id="E13" events="6" subjects_affected="5" subjects_at_risk="38"/>
                <counts group_id="E14" events="4" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E15" events="6" subjects_affected="6" subjects_at_risk="27"/>
                <counts group_id="E16" events="15" subjects_affected="12" subjects_at_risk="63"/>
                <counts group_id="E17" events="16" subjects_affected="13" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PRODUCTIVE COUGH</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="21"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E8" events="7" subjects_affected="6" subjects_at_risk="42"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E10" events="5" subjects_affected="5" subjects_at_risk="27"/>
                <counts group_id="E11" events="3" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="4" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E17" events="3" subjects_affected="3" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>OROPHARYNGEAL PAIN</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E12" events="5" subjects_affected="4" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="6" subjects_affected="5" subjects_at_risk="63"/>
                <counts group_id="E17" events="3" subjects_affected="3" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>NASAL CONGESTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="3" subjects_affected="3" subjects_at_risk="27"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="5" subjects_affected="4" subjects_at_risk="63"/>
                <counts group_id="E17" events="7" subjects_affected="5" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>RHINORRHOEA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="3" subjects_affected="3" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="4" subjects_affected="3" subjects_at_risk="63"/>
                <counts group_id="E17" events="4" subjects_affected="4" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>DYSPNOEA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="10" subjects_affected="10" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="5" subjects_affected="4" subjects_at_risk="63"/>
                <counts group_id="E17" events="10" subjects_affected="9" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>RALES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="4" subjects_affected="3" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>RESPIRATION ABNORMAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E8" events="8" subjects_affected="7" subjects_at_risk="42"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="2" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="9" subjects_affected="9" subjects_at_risk="63"/>
                <counts group_id="E17" events="20" subjects_affected="17" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>WHEEZING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>LUNG HYPERINFLATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>RESPIRATORY TRACT CONGESTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="6" subjects_affected="6" subjects_at_risk="63"/>
                <counts group_id="E17" events="6" subjects_affected="5" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>BRONCHIAL SECRETION RETENTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>HYPOVENTILATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>INCREASED VISCOSITY OF BRONCHIAL SECRETION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>NASAL MUCOSAL DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>NASAL OEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>OBSTRUCTIVE AIRWAYS DISORDER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PROLONGED EXPIRATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>RHINITIS ALLERGIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>RHONCHI</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>SINUS CONGESTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="3" subjects_affected="3" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E16" events="4" subjects_affected="4" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>SINUS DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>SNEEZING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>HAEMOPTYSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="23"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="21"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="3" subjects_affected="3" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="27"/>
                <counts group_id="E16" events="10" subjects_affected="7" subjects_at_risk="63"/>
                <counts group_id="E17" events="5" subjects_affected="5" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PLEURITIC PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="3" subjects_affected="3" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>EPISTAXIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PARANASAL SINUS HYPERSECRETION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>SPUTUM DISCOLOURED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>OBSTRUCTIVE AIRWAYS DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>BRONCHOSPASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>DYSPHONIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>DYSPNOEA EXERTIONAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>NASAL INFLAMMATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PAINFUL RESPIRATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PULMONARY CONGESTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>SPUTUM INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="12" subjects_affected="12" subjects_at_risk="63"/>
                <counts group_id="E17" events="10" subjects_affected="10" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>UPPER-AIRWAY COUGH SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="3" subjects_affected="3" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>BRONCHIAL OBSTRUCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>HICCUPS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>NASAL DRYNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PHARYNGEAL OEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PLEURISY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PULMONARY PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>RASH MACULAR</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>RASH PAPULAR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>ACNE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>DERMATITIS CONTACT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>HYPERHIDROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>HYPOAESTHESIA FACIAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>NIGHT SWEATS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>PRURITUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>RASH FOLLICULAR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>RASH MACULO-PAPULAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>URTICARIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Dermatitis atopic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>Rash generalised</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>RASH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E8" events="3" subjects_affected="3" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>ALOPECIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
              <event>
                <sub_title>ECCHYMOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hot flush</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="62"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Medical Monitor</name_or_title>
      <organization>Vertex Pharmaceuticals Incorporated</organization>
      <phone>617-341-6777</phone>
      <email>medicalinfo@vrtx.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

